Boston Scientific Valuation
| BSX Stock | USD 68.99 0.97 1.43% |
At this time, the firm appears to be fairly valued. Boston Scientific Corp shows a prevailing Real Value of $67.07 per share. The current price of the firm is $68.99. Our model approximates the value of Boston Scientific Corp from analyzing the firm fundamentals such as Current Valuation of 110.17 B, profit margin of 0.11 %, and Return On Equity of 0.0858 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Boston Scientific's valuation include:
Price Book 5.1893 | Enterprise Value 110.2 B | Enterprise Value Ebitda 31.5388 | Price Sales 7.0264 | Forward PE 30.2115 |
Fairly Valued
Today
Please note that Boston Scientific's price fluctuation is very steady at this time. Calculation of the real value of Boston Scientific Corp is based on 3 months time horizon. Increasing Boston Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Boston Scientific Corp is useful when determining the fair value of the Boston stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Boston Scientific. Since Boston Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boston Stock. However, Boston Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 68.99 | Real 67.07 | Target 61.18 | Hype 68.99 | Naive 68.57 |
The real value of Boston Stock, also known as its intrinsic value, is the underlying worth of Boston Scientific Corp Company, which is reflected in its stock price. It is based on Boston Scientific's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Boston Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Boston Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Boston Scientific Corp helps investors to forecast how Boston stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boston Scientific more accurately as focusing exclusively on Boston Scientific's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Boston Scientific's intrinsic value based on its ongoing forecasts of Boston Scientific's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Boston Scientific's closest peers. When choosing an evaluation method for Boston Scientific Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Boston Scientific Investments |
|
Boston Valuation Trend
Knowing Boston Scientific's actual value is paramount for traders to make sound investment determinations. Boston Scientific's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Boston Scientific's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Boston Scientific's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Boston Market Cap
Boston Scientific Corp is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 101.44 Billion. Boston Scientific totals roughly 101.41 Billion in market capitalization claiming about 100% of equities under Health Care industry.Boston Scientific Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boston Scientific competition to find correlations between indicators driving Boston Scientific's intrinsic value. More Info.Boston Scientific Corp is number one stock in price to earning category among related companies. It is rated third in price to book category among related companies fabricating about 0.05 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Boston Scientific Corp is roughly 20.63 . Price To Book Ratio is likely to rise to 5.87 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Boston Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Boston Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boston Scientific's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Boston Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Boston Scientific and how it compares across the competition.
About Boston Scientific Valuation
The stock valuation mechanism determines the current worth of Boston Scientific Corp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Boston Scientific Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Boston Scientific Corp based exclusively on its fundamental and basic technical indicators. By analyzing Boston Scientific's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Boston Scientific's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Boston Scientific. We calculate exposure to Boston Scientific's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Boston Scientific's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 9.9 B | 10.4 B | |
| Pretax Profit Margin | 0.14 | 0.15 | |
| Operating Profit Margin | 0.16 | 0.10 | |
| Net Profit Margin | 0.11 | 0.12 | |
| Gross Profit Margin | 0.69 | 0.77 |
8 Steps to conduct Boston Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Boston Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Boston Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Boston Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Boston Scientific's revenue streams: Identify Boston Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Boston Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Boston Scientific's growth potential: Evaluate Boston Scientific's management, business model, and growth potential.
- Determine Boston Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Boston Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Boston Scientific Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Boston Scientific does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.5 B | |
| Quarterly Earnings Growth Y O Y | 2.856 | |
| Forward Price Earnings | 30.2115 |
Boston Scientific Current Valuation Indicators
Valuation refers to the process of determining the present value of Boston Scientific Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Boston we look at many different elements of the entity such as Boston's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Boston Scientific's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Boston Scientific's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Boston Scientific, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Boston Scientific's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Boston Scientific's worth.When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.856 | Earnings Share 1.07 | Revenue Per Share 9.8 | Quarterly Revenue Growth 0.149 | Return On Assets 0.0447 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.